Literature DB >> 5575976

Dysgammaglobulinaemia complicated by disseminated measles.

H Mawhinney, I V Allen, J M Beare, J M Bridges, J H Connolly, M Haire, N C Nevin, D W Neill, J R Hobbs.   

Abstract

Mesh：

Substances：

Year:  1971        PMID： 5575976      PMCID： PMC1795778          DOI： 10.1136/bmj.2.5758.380

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  Attenuated measles vaccine in children with acute leukemia.

Authors:  A MITUS; A HOLLOWAY; A E EVANS; J F ENDERS
Journal:  Am J Dis Child       Date:  1962-03

2.  Measles-virus antibody and antigen in subacute sclerosing panencephalitis.

Authors:  J H Connolly; I V Allen; L J Hurwitz; J H Millar
Journal:  Lancet       Date:  1967-03-11       Impact factor: 79.321

3.  Measles as an index of immunological function.

Authors:  F M Burnet
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

4.  Rapid identification of rubella-virus antigen from throat swabs.

Authors:  M Haire
Journal:  Lancet       Date:  1969-05-03       Impact factor: 79.321
  4 in total
  12 in total

1.  Measles vaccination: Weighing the benefits and risks of a live viral vaccine for HIV-infected children.

Authors: 
Journal:  Can J Infect Dis       Date:  1996-07

2.  Rinderpest and peste des petits ruminants viruses exhibit neurovirulence in mice.

Authors:  Sareen E Galbraith; Stephen McQuaid; Louise Hamill; L Pullen; Thomas Barrett; S Louise Cosby
Journal:  J Neurovirol       Date:  2002-02       Impact factor: 2.643

Review 3.  Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity.

Authors:  Laura Pöyhönen; Jacinta Bustamante; Jean-Laurent Casanova; Emmanuelle Jouanguy; Qian Zhang
Journal:  J Clin Immunol       Date:  2019-05-23       Impact factor: 8.317

Review 4.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1972-06       Impact factor: 2.401

5.  Current status of vaccines and immune globulins for children with renal disease.

Authors:  R W Steele
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

6.  Role of biased hypermutation in evolution of subacute sclerosing panencephalitis virus from progenitor acute measles virus.

Authors:  T C Wong; M Ayata; S Ueda; A Hirano
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

Review 7.  Active immunization in the United States: developments over the past decade.

Authors:  P H Dennehy
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

8.  Introduction of measles into a highly immunised West African community: the role of health care institutions.

Authors:  P Aaby; J Bukh; I M Lisse; A J Smits
Journal:  J Epidemiol Community Health       Date:  1985-06       Impact factor: 3.710

9.  Altered virulence of vaccine strains of measles virus after prolonged replication in human tissue.

Authors:  A Valsamakis; P G Auwaerter; B K Rima; H Kaneshima; D E Griffin
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

Review 10.  Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination.

Authors:  Aline Baldo; Evanthia Galanis; Frédéric Tangy; Philippe Herman
Journal:  Hum Vaccin Immunother       Date:  2015-12-02       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.